Literature DB >> 19218703

The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients.

E Wysocka1, S Cofta, M Cymerys, J Gozdzik, L Torlinski, H Batura-Gabryel.   

Abstract

The aim of the study was to assess the markers of oxidant-antioxidant status in excess body mass index (BMI) persons with and without the obstructive sleep apnea syndrome (OSAS). In overweight (BMI-1: 25.0-29.9 kg/m(2)) control and OSAS and obese (BMI-2: 30.0-34.9 kg/m(2)) control and OSAS subjects with no acute or chronic disorder the following markers were determined: concentration of plasma total antioxidant status, TAS, (Randox); activity of erythrocyte Cu, Zn-superoxide dysmutase, SOD, (Randox); plasma concentration of thiobarbituric acid reacting substances, TBARS, (Yagi method). BMI-1-OSA presented decreased SOD, compared with the BMI-1-C group (P=0.006). BMI-2-OSA showed both SOD (P=0.002) and TAS (P=0.047) decreased, and elevated TBARS (P=0.03) compared with the BMI-2-C group. There was a positive correlation between TAS & SOD and a negative one between TAS & TBARS in the BMI-1-C group. In BMI-2-C, a negative correlation between TAS & TBARS was observed. We conclude that OSAS decreases the blood antioxidant status in high BMI persons and may change the relationship between oxidative stress markers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19218703

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  11 in total

1.  Treatment and prevention of inflammatory responses and oxidative stress in patients with obstructive sleep apnea hypopnea syndrome using Chinese herbal medicines.

Authors:  Qin Chen; Rong Jing Lin; Xuchu Hong; Lin Ye; Qichang Lin
Journal:  Exp Ther Med       Date:  2016-06-27       Impact factor: 2.447

2.  Proinflammatory and prothrombotic status in emphysematous rats exposed to intermittent hypoxia.

Authors:  Caili Li; Xiaokun Yang; Jing Feng; Ping Lei; Yubao Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  Adherence to CPAP therapy improves quality of life and reduces symptoms among obstructive sleep apnea syndrome patients.

Authors:  Eirini Avlonitou; Fotis Kapsimalis; George Varouchakis; Constantine I Vardavas; Panagiotis Behrakis
Journal:  Sleep Breath       Date:  2011-06-11       Impact factor: 2.816

4.  Investigation of the Plasma Nitrite Levels and Oxidant-Antioxidant Status in Obstructive Sleep Apnea Syndrome.

Authors:  Hakan Bozkurt; Abdurrahman Neyal; Sırma Geyik; Seyithan Taysi; Rüksan Anarat; Mesut Bulut; Ayşe Münife Neyal
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

Review 5.  Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS).

Authors:  Alessandra Quercioli; François Mach; Fabrizio Montecucco
Journal:  Sleep Breath       Date:  2010-03-03       Impact factor: 2.816

6.  Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients.

Authors:  M Simiakakis; F Kapsimalis; E Chaligiannis; S Loukides; N Sitaras; M Alchanatis
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

Review 7.  Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies.

Authors:  Hans-Joachim Eisele; Philipp Markart; Richard Schulz
Journal:  Oxid Med Cell Longev       Date:  2015-06-08       Impact factor: 6.543

8.  Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Carlos Zamarrón; Luis Valdés Cuadrado; Rodolfo Alvarez-Sala
Journal:  Pulm Med       Date:  2013-06-27

9.  The role of hyaluronic acid and hyaluronidase-1 in obstructive sleep apnoea.

Authors:  Martina Meszaros; Adrian Kis; Laszlo Kunos; Adam Domonkos Tarnoki; David Laszlo Tarnoki; Zsofia Lazar; Andras Bikov
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

Review 10.  Oxidative Stress Markers among Obstructive Sleep Apnea Patients.

Authors:  Agata Stanek; Klaudia Brożyna-Tkaczyk; Wojciech Myśliński
Journal:  Oxid Med Cell Longev       Date:  2021-07-19       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.